ArticleCell death discovery2023

Kinome-wide CRISPR-Cas9 knockout screens revealed PLK1 as a therapeutic target for osteosarcoma.

Renxian Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.